医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Irvine Scientific Announces Its Tokyo Facility Has Received ISO 9001:2008 CERTIFICATION

2013年02月27日 PM09:40
このエントリーをはてなブックマークに追加


 

SANTA ANA, Calif.

Irvine Scientific, a member of JX group, is proud to announce that its Tokyo manufacturing facility received Certification to the ISO 9001:2008 International Quality Standard.

The Irvine Scientific Tokyo site is pleased to have successfully developed a quality management system and state-of-the-art operations that meets rigorous standards and expectations of the customers we serve.

The Irvine Scientific – Tokyo manufacturing facility was commissioned in July, 2010 for the production of Industrial Cell Culture Media. Developed as a completely Animal Component Free (ACF) facility to provide redundancy to Irvine Scientific’s California facility, Tokyo production supports biopharmaceutical and vaccine customers. The Certification was achieved to complete the mission of providing complete redundancy in the design and control of Irvine Scientific’s manufacturing sites. The Tokyo site successfully achieved the certification award after completing and implementing the quality management system used by Irvine Scientific other sites. This Quality systems used by Irvine Scientific is designed to provide world-class standard of manufacture while meeting other requirements of the industrial and cell culture media customers.

The certification is further illustration of Irvine Scientific and the JX Groups’ commitment to providing quality products and services to the industrial, research and biomedical laboratories served.

About Irvine Scientific:

Irvine Scientific, a member of JX group, is a worldwide leader in the design, manufacture and distribution of medical devices, including Industrial Cell Culture, Cytogenetic, Assisted Reproductive Technology (ART) and Specialty Media products. Irvine Scientific is a worldwide media provider that is regulated and adheres to both ISO and FDA regulations with dual manufacturing facilities in California, USA and Tokyo, Japan.

Irvine Scientific is a large scale producer of advanced quality cell culture media for the industrial bioprocess, medical, and diagnostic markets. The company’s extensive experience in the design of culture media, compliance with ISO and FDA regulations for class II / III medical devices, industrial scale manufacturing capacity, provides its customers with unique capabilities and support.

CONTACT

Irvine Scientific
Ms. Makenzie Carter, +949-261-7800 x202
mcarter@irvinesci.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402
  • Bertin与Zymo Research宣布达成新的合作